As social determinants of health become a common conversation in healthcare, loneliness and social isolation are rising to the forefront.
Medicaid and ACA enrollment, and coverage for COVID-19 tests will be impacted once the PHE comes to an end.
Leaders gathered in Davos examined how to apply lessons learned from COVID-19 to preventing future pandemics and reducing health inequities.
The increased need for behavioral healthcare is putting pressure on a system that is ill-prepared to deal with an influx of patients.
Cell and gene therapies hold tremendous promise for patients and the industry, but new business models are needed to get innovations to patients.
In today's hyperconnected world, organizations have to work together to defend against cyber attacks. And they need to embed secure technology and procedures more widely.
As the Biden administration leans into the Cancer Moonshot 2.0, the life sciences industry has the opportunity to launch a new era of precision oncology. How can we accelerate progress toward truly personalized medicine and revolutionize cancer care?
CMS released the next evolution of Direct Contracting, boosting the program’s attractiveness and its focus on health equity, as well as scrapping the Geo program.
The 2022 Global Risks Report — prepared by the World Economic Forum with the support of Marsh McLennan and other partners — examines conflicting response strategies to the pandemic.
Having a deep understanding of your enrollees and the communities they in live empowers organizations to address critical needs in a meaningful way.